
The exemptions are part of the implementation of Trump's April proclamation adjusting imports of pharmaceuticals and pharmaceutical ingredients under Section 232 of the Trade Expansion Act.
The exemptions are part of the implementation of Trump's April proclamation adjusting imports of pharmaceuticals and pharmaceutical ingredients under Section 232 of the Trade Expansion Act.

This article was originally published by an external source. Read the full story at the source.
Read Full Article at Source ↗